McLean E M, Driver H, McDanell R
Department of Clinical Pharamacology, School of Medicine, University College London, UK.
Bull Cancer. 1990;77(5):505-8.
Phenobarbital and other substances that cause induction of P450 linked enzymes in the liver are potent tumour promoters when given to rats after a single dose of dimethyl or diethyl nitrosamine. The human population is known to be exposed to small amounts of nitrosamines and to inducers of P450 linked enzymes in the liver, from natural foods such as cabbage and other brassicas. Many individuals are exposed to induced doses of phenobarbital used as anti convulsants. Cohort studies have shown that there is no increased risk of liver cancer detectable in people taking phenobarbital who suffer from epilepsy. On investigating the dose response curve for tumour promotion one finds that hepatocellular carcinomas only appear at a high dosage of phenobarbital and it seems likely that the human exposure to inducers in food, and in therapy with anticonvulsants, is in the dosage range well below that which causes promotion of liver cancer. The physiological adaptation to environment must be clearly distinguished from the pathological events which take place in experimental overdose.
苯巴比妥及其他可诱导肝脏中与P450相关酶的物质,在大鼠单次给予二甲基或二乙基亚硝胺后给药时,是强效的肿瘤促进剂。已知人类会从诸如卷心菜和其他十字花科蔬菜等天然食物中接触少量亚硝胺和肝脏中与P450相关酶的诱导剂。许多人会接触到用作抗惊厥药的诱导剂量的苯巴比妥。队列研究表明,患有癫痫的人服用苯巴比妥后,未发现患肝癌风险增加。在研究肿瘤促进的剂量反应曲线时发现,只有在高剂量的苯巴比妥时才会出现肝细胞癌,而且人类从食物和抗惊厥药治疗中接触诱导剂的剂量范围似乎远低于导致肝癌促进的剂量。必须明确区分对环境的生理适应与实验性过量时发生的病理事件。